Evidence for early cognitive impairment related to frontal cortex in the 5xFAD mouse model of Alzheimer’s disease.

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859 · see citing works

Image processing with ImageJ

Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 11,816 · see citing works

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · see citing works

Neural mechanisms of ageing and cognitive decline

Bishop, N. A., Lu, T., & Yankner, B. A. (2010) · Nature · doi:10.1038/nature08983 · Cited by 1,323 · see citing works

Executive functions and the frontal lobes: a conceptual view

Stuss, D. T., & Alexander, M. P. (2000) · Psychological Research · doi:10.1007/s004269900007 · Cited by 1,159 · see citing works

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease

Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720 · see citing works

THE DECLINE OF WORKING MEMORY IN ALZHEIMER'S DISEASE

Baddeley, A., Bressi, S., Sala, S. D., Logie, R. H., & Spinnler, H. R. (1991) · Brain · doi:10.1093/brain/114.6.2521 · Cited by 699 · see citing works

Animal models of Alzheimer's disease and frontotemporal dementia

Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · see citing works

Synaptic degeneration in Alzheimer's disease

Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · see citing works

Memory and Brain Systems: 1969–2009

Squire, L. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3575-09.2009 · Cited by 477 · see citing works

Alzheimer disease models and human neuropathology: similarities and differences

Duyckaerts, C. J., Potier, M., & Delatour, B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 441 · see citing works

Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model

Wesson, D. W., Levy, E., Nixon, R. A., & Wilson, D. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4622-09.2010 · Cited by 290 · see citing works

Selective Preservation and Degeneration Within the Prefrontal Cortex in Aging and Alzheimer Disease

Salat, D. H., Kaye, J. A., & Janowsky, J. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1403 · Cited by 261 · see citing works

Executive dysfunction in Alzheimer's disease.

Collette, F., der Linden, M. V., & Salmon, É. (1999) · Cortex; a journal devoted to the study of the nervous system and behavior · doi:10.1016/s0010-9452(08)70785-8 · Cited by 238 · see citing works

Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys.

Bättig, K., Rosvold, H. E., & Mishkin, M. (1960) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0047392 · Cited by 236 · see citing works

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F. (2010) · Brain · doi:10.1093/brain/awq258 · Cited by 230 · see citing works

Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease

Ashe, K. H. (2001) · Learning & Memory · doi:10.1101/lm.43701 · Cited by 224 · see citing works

Examination of the working memory components in normal aging and in dementia of the Alzheimer type

Belleville, S., Peretz, I., & Malenfant, D. (1996) · Neuropsychologia · doi:10.1016/0028-3932(95)00097-6 · Cited by 213 · see citing works

Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease

Horwitz, B., Grady, C. L., Schlageter, N. L., Duara, R., & Рапопорт, С. И. (1987) · Brain Research · doi:10.1016/0006-8993(87)91107-3 · Cited by 181 · see citing works

Delusional Thoughts and Regional Frontal/Temporal Cortex Metabolism in Alzheimer’s Disease

Sultzer, D. L., Brown, C. V., Mandelkern, M. A., Mahler, M. E., Mendez, M. F., Chen, S. T., & Cummings, J. L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.341 · Cited by 176 · see citing works

Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease

Kashani, A., Lepicard, E. M., Poirel, O., Videau, C., David, J. P., Fallet‐Bianco, C., Simon, A., Delacourte, A., Bruno Giros, A., Epelbaum, J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.010 · Cited by 175 · see citing works

Cortical Synaptic Changes and Gliosis in Normal Aging, Alzheimer's Disease and Frontal Lobe Degeneration

Liu, X., Erikson, C., & Brun, A. E. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106867 · Cited by 152 · see citing works

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J. K., Tamminen, J. N., Tillgren, T., Vainikka, S., Pyykkö, O. T., Mölsä, J. A. A., zu Fraunberg, M. V. U., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22100 · Cited by 149 · see citing works

Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease

Schro¨der, H., Ezio, G., Struble, R. G., Zilles, K., & Maelicke, A. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90107-u · Cited by 148 · see citing works

Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration

Eriksen, J. L., & Janus, C. G. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9118-z · Cited by 146 · see citing works

Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies

Muntané, G., Dalfó, E., Martı́nez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 143 · see citing works

Random number generation in dementia of the Alzheimer type: A test of frontal executive functions

Brugger, P., Monsch, A. U., Salmon, D. P., & Butters, N. (1996) · Neuropsychologia · doi:10.1016/0028-3932(95)00066-6 · Cited by 120 · see citing works

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer’s disease

Kalinin, S., Polak, P. E., Lin, S. X., Sakharkar, A. J., Pandey, S. C., & Feinstein, D. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.012 · Cited by 116 · see citing works

Delayed response tasks and prefrontal lesions in man—Evidence for self generated patterns of behaviour with poor environmental modulation

Vérin, M., Partiot, A., Pillon, B., Malapani, C., Agid, Y., & Dubois, B. (1993) · Neuropsychologia · doi:10.1016/0028-3932(93)90105-9 · Cited by 109 · see citing works

Disconnection of Frontal and Parietal Areas Contributes to Impaired Attention in Very Early Alzheimer's Disease

Neufang, S., Akhrif, A., Riedl, V., Förstl, H., Kurz, A., Zimmer, C., Sorg, C., & Wohlschläger, A. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102154 · Cited by 99 · see citing works

Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease

Cassano, T., Serviddio, G., Gaetani, S., Romano, A., Dipasquale, P., Cianci, S., Bellanti, F., Laconca, L., Romano, A. D., Padalino, I., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.021 · Cited by 99 · see citing works

Synapse Loss and Gliosis in the Molecular Layer of the Cerebral Cortex in Alzheimer's Disease and in Frontal Lobe Degeneration

Brun, A. E., Liu, X., & Erikson, C. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0021 · Cited by 96 · see citing works

Effect of manipulation and irrelevant noise on working memory capacity of patients with Alzheimer's dementia.

Belleville, S., Rouleau, N., der Linden, M. V., & Collette, F. (2003) · Neuropsychology · doi:10.1037/0894-4105.17.1.69 · Cited by 85 · see citing works

Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat

Dunnett, S. B., Meldrum, A., & Muir, J. L. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.033 · Cited by 70 · see citing works

Genetic reductions of BACE1 and amyloid-β ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer model mice

Devi, L., & Ohno, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07031.x · Cited by 67 · see citing works

Differences in Cortical Thickness in Healthy Controls, Subjects with Mild Cognitive Impairment, and Alzheimer's Disease Patients: A Longitudinal Study

Julkunen, V., Niskanen, E. I., Koikkalainen, J. R., Herukka, S., Pihlajamaki, M. M., Hallikainen, M., Kivipelto, M., Muehlboeck, S., Evans, A. C., Vanninen, R. L., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100114 · Cited by 62 · see citing works

Should olfactory dysfunction be used as a biomarker of Alzheimer’s disease?

Wesson, D. W., Wilson, D. A., & Nixon, R. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.33 · Cited by 58 · see citing works

Effects of rat medial prefrontal cortex temporal inactivation on a delayed alternation task

Izaki, Y., Maruki, K., Hori, K., & Nomura, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02366-7 · Cited by 46 · see citing works

Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer’s Disease

Apostolova, L. G., Hwang, K., Medina, L. D., Green, A. E., Braskie, M. N., Dutton, R. A., Lai, J., Geschwind, D. H., Cummings, J. L., Thompson, P. M., et al. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330471 · Cited by 31 · see citing works

Making your next move: Dorsolateral prefrontal cortex and planning a sequence of actions in freely moving monkeys

Ryou, J. W., & Wilson, F. A. W. (2004) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/cabn.4.4.430 · Cited by 28 · see citing works

The olfactory tubing maze: a new apparatus for studying learning and memory processes in mice

Roman, F. S., Marchetti, E., Bouquerel, A., & Soumireu-Mourat, B. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00094-8 · Cited by 27 · see citing works

Perseveration related to frontal lesion in mice using the olfactory H-maze

Del’Guidice, T., Nivet, E., Escoffier, G., Baril, N., Caverni, J.-P., & Roman, F. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.08.007 · Cited by 13 · see citing works

The functional neuroanatomy of classic delayed response tasks in humans and the limitations of cross-method convergence in prefrontal function

Turner, G. R., & Levine, B. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.067 · Cited by 10 · see citing works

A novel experimental paradigm for studying cognitive functions related to delayed response tasks in mice

Belhaoues, R., Soumireu-Mourat, B., Caverni, J., & Roman, F. S. (2005) · HAL · Cited by 5 · see citing works

Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways.

Lavenex (2000) · Pure Amsterdam UMC · doi:10.1002/1098-1063(2000)10:4 · Cited by 1 · see citing works

Comprehensive evaluation of the 5xFAD mouse model for preclinical testing applications: A MODEL-AD study.

Oblak, A. L., Lin, P. B., Kotredes, K. P., Pandey, R. S., Garceau, D., Williams, H. M., Uyar, A., O’Rourke, R., O’Rourke, S., Ingraham, C., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.713726 · Cited by 325 · see citing works

Genetic mouse models of brain ageing and Alzheimer's disease

Bilkei‐Gorzó, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.009 · Cited by 244 · see citing works

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease

Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-33 · Cited by 176 · see citing works

Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model

Cai, M., Lee, J., & Yang, E. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1665-3 · Cited by 159 · see citing works

Repetitive transcranial magnetic stimulation increases the brain’s drainage efficiency in a mouse model of Alzheimer’s disease

Lin, Y., Jin, J., Lv, R., Luo, Y. M., Dai, W.-P., Li, W., Tang, Y., Wang, Y., Ye, X., & Lin, W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01198-3 · Cited by 138 · see citing works

MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease

Baranger, K., Marchalant, Y., Bonnet, A. E., Crouzin, N., Carreté, A., Paumier, J., Py, N. A., Bernard, A., Bauer, C., Charrat, E., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1992-1 · Cited by 127 · see citing works

Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders

Rivera, S., García‐González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 112 · see citing works

Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer’s Disease: Dissociation between Somatosensory Cortex and Hippocampus

Crouzin, N., Baranger, K., Cavalier, M., Marchalant, Y., Cohen‐Solal, C., Roman, F. S., Khrestchatisky, M., Rivera, S., Feron, F. P., & Vignes, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074667 · Cited by 111 · see citing works

Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease

Giannoni, P., Gaven, F., Bundel, D. D., Baranger, K., Marchetti, E., Roman, F. S., Valjent, E., Marin, P., Bockaert, J., Rivera, S., et al. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00096 · Cited by 108 · see citing works

Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease

Andersen, J. V., Christensen, S. K., Westi, E. W., Diaz‐delCastillo, M., Tanila, H., Schousboe, A., Aldana, B. I., & Waagepetersen, H. S. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105198 · Cited by 106 · see citing works

Increased fragmentation of sleep–wake cycles in the 5XFAD mouse model of Alzheimer’s disease

Sethi, M., Joshi, S., Webb, R. L., Beckett, T. L., Donohue, K. D., Murphy, M. P., O’Hara, B. F., & Duncan, M. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.035 · Cited by 104 · see citing works

Environmental Enrichment Improves Cognitive Deficits, AD Hallmarks and Epigenetic Alterations Presented in 5xFAD Mouse Model

Griñán-Ferré, C., Izquierdo, V., Otero, E., Puigoriol-Illamola, D., Corpas, R., Sanfeliu, C., Ortuño-Sahagún, D., & Pallàs, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00224 · Cited by 94 · see citing works

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease

Griñán‐Ferré, C., Codony, S., Pujol, E., Yang, J., Leiva, R., Escolano, C., Puigoriol‐Illamola, D., Companys‐Alemany, J., Corpas, R., Sanfeliu, C., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00854-1 · Cited by 89 · see citing works

Amyloid-β Deposition and Olfactory Dysfunction in an Alzheimer's Disease Model

Wu, N., Rao, X., Gao, Y., Wang, J., & Xu, F. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-122443 · Cited by 89 · see citing works

Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer’s disease: evidence for a pro-amyloidogenic role of MT1-MMP

Py, N., Bonnet, A., Bernard, A., Marchalant, Y., Charrat, E., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00247 · Cited by 71 · see citing works

Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model

Griñán‐Ferré, C., Marsal-García, L., Bellver‐Sanchís, A., Kondengaden, S. M., Turaga, R. C., Vázquez, S., & Pallàs, M. (2019) · Aging · doi:10.18632/aging.102558 · Cited by 85 · see citing works

Behaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model

Pádua, M. S., Guil‐Guerrero, J. L., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126766 · Cited by 87 · see citing works

Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

García‐González, L., Piłat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 81 · see citing works

Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse

Macdonald, I. R., DeBay, D. R., Reid, G. A., O’Leary, T. P., Jollymore, C. T., Mawko, G., Burrell, S., Martin, E., Bowen, C. V., Brown, R. E., et al. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140505111354 · Cited by 79 · see citing works

Olfactory Dysfunction in the Elderly: Basic Circuitry and Alterations with Normal Aging and Alzheimer’s Disease

Masurkar, A. V., & Devanand, D. P. (2014) · Current Geriatrics Reports · doi:10.1007/s13670-014-0080-y · Cited by 75 · see citing works

Comparison of memory, affective behavior, and neuropathology in APPNLGF knock-in mice to 5xFAD and APP/PS1 mice

Locci, A., Orellana, H., Rodríguez, G., Gottliebson, M., McClarty, B. M., Dominguez, S., Keszycki, R. M., & Dong, H. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113192 · Cited by 68 · see citing works

Molecular Differences and Similarities between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis

Maarouf, C. L., Kokjohn, T. A., Whiteside, C. M., Macias, M. P., Kalback, W. M., Sabbagh, M. N., Beach, T. G., Vassar, R. J., & Roher, A. E. (2013) · Biochemistry Insights · doi:10.4137/bci.s13025 · Cited by 66 · see citing works

Recognition and Removal of Amyloid‐β by a Heteromultivalent Macrocyclic Coassembly: A Potential Strategy for the Treatment of Alzheimer's Disease

Wang, H., Xu, X., Pan, Y., Yan, Y., Hu, X., Chen, R., Ravoo, B. J., Guo, D., & Zhang, T. (2020) · Advanced Materials · doi:10.1002/adma.202006483 · Cited by 61 · see citing works

Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APPNL-F/NL-F knock-in mice

Shah, D., Latif‐Hernandez, A., Strooper, B. D., Saito, T., Saido, T. C., Verhoye, M., D’Hooge, R., & der Linden, A. V. (2018) · Scientific Reports · doi:10.1038/s41598-018-24657-9 · Cited by 58 · see citing works

MT5-MMP Promotes Alzheimer’s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro

Baranger, K., Bonnet, A. E., Girard, S. D., Paumier, J., García‐González, L., Manaa, W. E., Bernard, A., Charrat, E., Stephan, D., Bauer, C., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00163 · Cited by 52 · see citing works

MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer’s Disease

Jeong, Y.-O., Shin, S. J., Park, J., Ku, B., Song, J.-S., Kim, J.-J., Jeon, S., Lee, S. M., & Moon, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061800 · Cited by 48 · see citing works

Sex and Genotype Differences in Odor Detection in the 3×Tg-AD and 5XFAD Mouse Models of Alzheimer’s Disease at 6 Months of Age

Roddick, K. M., Roberts, A. D., Schellinck, H. M., & Brown, R. E. (2016) · Chemical Senses · doi:10.1093/chemse/bjw018 · Cited by 51 · see citing works

Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms

Sarroca, S., Gatius, A., Rodrı́guez-Farré, E., Vı́lchez, D., Pallàs, M., Griñán‐Ferré, C., Sanfeliu, C., & Corpas, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108569 · Cited by 52 · see citing works

Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer’s disease

Zhang, M., Zhang, Z., Li, H., Xia, Y., Xing, M., Xiao, C., Cai, W., Bu, L.-L., Li, Y., Park, T., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00388-4 · Cited by 49 · see citing works

Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging

Tang, X., Wu, D., Gu, L., Nie, B., Qi, X., Wang, Y., Wu, F., Li, X.-L., Bai, F., Chen, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11353 · Cited by 46 · see citing works

Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research

Pádua, M. S., Guil-Guerrero, J. L., Prates, J. A. M., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052805 · Cited by 46 · see citing works

Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer’s Disease, and Other Neurodegenerative Disorders

Cutuli, D., Landolfo, E., Petrosini, L., & Gelfo, F. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215193 · Cited by 46 · see citing works

Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer’s Disease-Related Mice

Ali, F., Baringer, S. L., Neal, A., Choi, E. Y., & Kwan, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181190 · Cited by 43 · see citing works

Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice

Binyamin, O., Nitzan, K., Frid, K., Ungar, Y., Rosenmann, H., & Gabizon, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-54971-9 · Cited by 43 · see citing works

Stimulation of 5-HT2C Receptors Improves Cognitive Deficits Induced by Human Tryptophan Hydroxylase 2 Loss of Function Mutation

Del’Guidice, T., Lemay, F., Lemasson, M., Levasseur‐Moreau, J., Manta, S., Etiévant, A., Escoffier, G., Doré, F. Y., Roman, F. S., & Beaulieu, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.313 · Cited by 41 · see citing works

Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer’s Disease and Dementia

Shepherd, A. L., Tyebji, S., Hannan, A. J., & Burrows, E. L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0837-1 · Cited by 42 · see citing works

Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

Zhao, H., Li, X., Wu, W., Li, Z., Qian, L., Li, S., Zhang, B., & Xu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130017 · Cited by 43 · see citing works

Olfactory delayed matching to sample performance in mice: Sex differences in the 5XFAD mouse model of Alzheimer's disease

Roddick, K. M., Schellinck, H. M., & Brown, R. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.038 · Cited by 37 · see citing works

Transient Cerebral Ischemia Promotes Brain Mitochondrial Dysfunction and Exacerbates Cognitive Impairments in Young 5xFAD Mice

Lu, L., Guo, L., Gauba, E., Tian, J., Wang, L., Tandon, N., Shankar, M., Beck, S. J., Du, Y., & Du, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144068 · Cited by 36 · see citing works

Neuroimaging of mouse models of Alzheimer’s disease

Jullienne, A., Trinh, M. V., & Obenaus, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020305 · Cited by 32 · see citing works

Path Integration Changes as a Cognitive Marker for Vascular Cognitive Impairment?—A Pilot Study

Lowry, E., Puthusseryppady, V., Coughlan, G., Jeffs, S., & Hornberger, M. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.00131 · Cited by 31 · see citing works

Age related weight loss in female 5xFAD mice from 3 to 12 months of age

Gendron, W. A. C., Fertan, E., Pelletier, S., Roddick, K. M., O’Leary, T. P., Anini, Y., & Brown, R. E. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113214 · Cited by 31 · see citing works

Recognition memory impairments and amyloid-beta deposition of the retrosplenial cortex at the early stage of 5XFAD mice

Kim, D.-H., Kim, H.-A., Han, Y. S., Jeon, W. K., & Han, J. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112891 · Cited by 30 · see citing works

Electroacupuncture Enhances Cognition by Promoting Brain Glucose Metabolism and Inhibiting Inflammation in the APP/PS1 Mouse Model of Alzheimer’s Disease: A Pilot Study

Xu, A., Tang, Y., Zeng, Q., Wang, X., Tian, H., Zhou, Y., & Li, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200242 · Cited by 30 · see citing works

Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer’s disease

Jullienne, A., Szu, J. I., Quan, R., Trinh, M. V., Norouzi, T., Noarbe, B. P., Bedwell, A. A., Eldridge, K., Persohn, S. A., Territo, P. R., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1220036 · Cited by 30 · see citing works

Olfactory impairment in men and mice related to aging and amyloid-induced pathology

Tzeng, W.-Y., Figarella, K., & Garaschuk, O. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02527-0 · Cited by 27 · see citing works

The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease

Viola, K. L., Bicca, M. A., Bebenek, A. M., Kranz, D. L., Nandwana, V., Waters, E. A., Haney, C. R., Lee, M. Y., Gupta, A., Brahmbhatt, Z., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.768646 · Cited by 29 · see citing works

The Effect of Thymoquinone, α7 Receptor Agonist and α7 Receptor Allosteric Modulator on the Cerebral Cortex in Experimentally Induced Alzheimer's Disease in Relation to MSCs Activation

Elfattah, L. I. A., Zickri, M. B., Kassem, L. A. A., Heikal, O. A., & Osama, E. (2016) · International Journal of Stem Cells · doi:10.15283/ijsc16021 · Cited by 20 · see citing works

Learning strategy preference of 5XFAD transgenic mice depends on the sequence of place/spatial and cued training in the water maze task

Cho, W.-H., Park, J.-C., Chung, C., Jeon, W. K., & Han, J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.033 · Cited by 19 · see citing works

Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease

Drew, V. J., Wang, C., & Kim, T. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119810 · Cited by 19 · see citing works

4-Hydroxynonenal Immunoreactivity Is Increased in the Frontal Cortex of 5XFAD Transgenic Mice

Shin, S.-W., Kim, D.-H., Jeon, W. K., & Han, J. (2020) · Biomedicines · doi:10.3390/biomedicines8090326 · Cited by 17 · see citing works

The 5×FAD mouse model of Alzheimer's disease

Ismeurt, C., Giannoni, P., & Claeysen, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00013-6 · Cited by 16 · see citing works

Impairments in endogenous AMPA receptor dynamics correlates with learning deficits in Alzheimer’s disease model mice

Lu, K., Li, C., Liu, J., Wang, J., Li, Y., He, B., Li, J., Zhang, X., Wei, M., Tian, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303878120 · Cited by 14 · see citing works

Procognitive and neurotrophic benefits of α5-GABA-A receptor positive allosteric modulation in a β-amyloid deposition mouse model of Alzheimer’s disease pathology

Bernardo, A. M., Marcotte, M. D., Wong, K. D., Sharmin, D., Pandey, K. P., Cook, J. M., Sibille, E. L., & Prévot, T. D. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.12.001 · Cited by 15 · see citing works

Age-related deficits in working memory in 5xFAD mice in the Hebb-Williams maze

Fertan, E., & Brown, R. E. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113806 · Cited by 14 · see citing works

ID1201, the ethanolic extract of the fruit of Melia toosendan ameliorates impairments in spatial learning and reduces levels of amyloid beta in 5XFAD mice

Cho, W.-H., Park, J.-C., Kim, D.-H., Kim, M.-S., Lee, S.-Y., Park, H., Kang, J.-H., Yeon, S.-W., & Han, J.-S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.09.036 · Cited by 13 · see citing works

Neurodegenerative changes in the brains of the 5xFAD Alzheimer's disease model mice investigated by high‐field and high‐resolution magnetic resonance imaging and multi‐nuclei magnetic resonance spectroscopy

Yoo, C.-H., Kim, J., Baek, H.-M., Chang, K.-A., & Choe, B.-Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065073 · Cited by 13 · see citing works

Activation of Gq-Coupled Receptors in Astrocytes Restores Cognitive Function in Alzheimer’s Disease Mice Model

Gerasimov, E., Борисович, Б. И., & Власова, О. Л. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129969 · Cited by 13 · see citing works

Bridging the Gap between Gut Microbiota and Alzheimer’s Disease: A Metaproteomic Approach for Biomarker Discovery in Transgenic Mice

Ayan, E. B., DeMi̇rci̇, H., Serdar, M. A., Palermo, F., & Baykal, A. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612819 · Cited by 13 · see citing works

Comparative Histological Study on the Therapeutic Effect of Green Tea and Stem Cells in Alzheimer’s Disease Complicating Experimentally Induced Diabetes

Bassiouny, H. S., Zickri, M. B., Metwally, H. G., Elsherif, H. A., Alghandour, S. M., & Sakr, W. (2015) · International Journal of Stem Cells · doi:10.15283/ijsc.2015.8.2.181 · Cited by 13 · see citing works

Neonatal Neurodegeneration in Alzheimer’s Disease Transgenic Mouse Model

Mazi, A. R., Arzuman, A. S., Gürel, B., Şahin, B., Tüzüner, M. B., Ozansoy, M., & Baykal, A. T. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170049 · Cited by 13 · see citing works

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy

Ortiz-Islas, E., Montes, P., Rodríguez-Pérez, C. E., Ruiz-Sánchez, E., Sánchez-Barbosa, T., Pichardo-Rojas, D., Zavala‐Tecuapetla, C., Carvajal, K., & Campos‐Peña, V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010128 · Cited by 12 · see citing works

Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice

Shin, S. J., Jeong, Y.-O., Jeon, S. G., Kim, S., Lee, S.-K., Nam, Y., Park, Y., Kim, D., Lee, Y. S., Choi, H. S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124026 · Cited by 12 · see citing works

Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model

Baranger, K., van Gijsel‐Bonnello, M., Stephan, D., Carpentier, W., Rivera, S., Khrestchatisky, M., Gharib, B., Reggi, M. L. D., & Benech, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00754-z · Cited by 12 · see citing works

Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging

Maharjan, S., Tsai, A. P., Lin, P. B., Ingraham, C., Jewett, M. R., Landreth, G. E., Oblak, A. L., & Wang, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.964654 · Cited by 11 · see citing works

Characterization of cerebrovascular changes in Alzheimer’s disease mice by photoacoustic imaging

Li, X., Zhang, Z., Shi, H., & Zhou, F. (2024) · Journal of Innovative Optical Health Sciences · doi:10.1142/s179354582450007x · Cited by 9 · see citing works

Identifying the bioimaging features of Alzheimer’s disease based on pupillary light response-driven brain-wide fMRI in awake mice

Liu, X., Hike, D., Choi, S., Man, W., Ran, C., Zhou, X. A., Jiang, Y., & Yu, X. (2024) · Nature Communications · doi:10.1038/s41467-024-53878-y · Cited by 9 · see citing works

Ginkgolide A enhances cognition and reduces amyloid-β by activating autophagy in the murine 5xFAD Alzheimer’s disease model

Park, S., Park, M., & Lee, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118472 · Cited by 10 · see citing works

Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing

Shepherd, A. L., Lim, J. K. H., Wong, V. H. Y., Zeleznikow-Johnston, A., Churilov, L. P., Nguyen, C. T. O., Bui, B. V., Hannan, A. J., & Burrows, E. L. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.004 · Cited by 8 · see citing works

Cyclopentanone Derivative Attenuates Memory Impairment by Inhibiting Amyloid Plaques Formation in the 5xFAD Mice

Ullah, R., Ali, G., Khan, A., Ahmad, S., & Al‐Harrasi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179559 · Cited by 7 · see citing works

Intranasal insulin treatment ameliorates spatial memory, muscular strength, and frailty deficits in 5xFAD mice

Gendron, W. A. C., Fertan, E., Roddick, K. M., Wong, A. A., Maliougina, M., Hiani, Y. E., Anini, Y., & Brown, R. E. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114583 · Cited by 7 · see citing works

An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease

Lopes, P. A., Pádua, M. S., & Guil‐Guerrero, J. L. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2010002 · Cited by 8 · see citing works

Disruption of hippocampal-prefrontal neural dynamics and risky decision-making in a mouse model of Alzheimer’s disease

Kim, E. J., Park, S., Schuessler, B. P., Boo, H., Cho, J., & Kim, J. J. (2024) · bioRxiv · doi:10.1016/j.celrep.2025.116081 · Cited by 6 · see citing works

Neuronal Count, Brain Injury, and Sustained Cognitive Function in 5×FAD Alzheimer’s Disease Mice Fed DHA-Enriched Diets

de Mello-Sampayo, C., Pádua, M. S., Silva, M. R., Lourenço, M. E. M., Pinto, R. M. A., Carvalho, S., Correia, J., Martins, C. F., Gomes, R., Gomes‐Bispo, A., et al. (2025) · Biomolecules · doi:10.3390/biom15081164 · Cited by 6 · see citing works

Sex‐specific mechanisms of cerebral microvascular BK Ca dysfunction in a mouse model of Alzheimer's disease

da Silva, J. F., Polk, F. D., Martin, P. E., Thai, S. H., Savu, A., Gonzales, M., Kath, A., Gee, M. T., & Pires, P. W. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14438 · Cited by 6 · see citing works

Diet enriched in omega‐3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice

Lessard‐Beaudoin, M., Gonzalez, L. M., Alotaibi, M. M., Chouinard‐Watkins, R., Plourde, M., Calon, F., & Graham, R. K. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15472 · Cited by 6 · see citing works

The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives

Baldasso, G. M., Paes, R. S., Moreira, A. F., Salvadori, S. G., Limberger, C., Roviezzo, F., Capasso, R., & Dutra, R. C. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108185 · Cited by 6 · see citing works

Human iPSC‐Derived Mononuclear Phagocytes Improve Cognition and Neural Health across Multiple Mouse Models of Aging and Alzheimer's Disease

Moser, V., Dimas-Harms, L. J., Lipman, R. M., Inzalaco, J., Bell, S., Alcântara, M., Valenzuela, E., Lawless, G., Kreimer, S. D., Parker, S. J., et al. (2025) · Advancement of science · doi:10.1002/advs.202417848 · Cited by 5 · see citing works

Platycodin D and voluntary running synergistically ameliorate memory deficits in 5 × FAD mice via mediating neuromodulation and neuroinflammation

Liu, J., Jiang, J., He, C., Zhou, L., Zhang, Y., Zhao, S., & Yang, Z. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1451766 · Cited by 6 · see citing works

Animal Models for Brain Research

Dam, D. V., & Deyn, P. P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_1 · Cited by 3 · see citing works

Auditory sensory processing induces cortical and thalamic event-related desynchronization in the mouse

McGill, S. H., Xin, Q., Yadav, T., Zhao, C. W., Paszkowski, P., Darby, F., Guha, M., Nguyen, T., Jin, D. S., Nir, Y., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334293 · Cited by 2 · see citing works

Retinal Degeneration in Alzheimer’s Disease 5xFAD Mice Fed DHA-Enriched Diets

Pinho, M., Ahfaz, H., Carvalho, S., Correia, J., Spínola, M. P., Pestana, J. M., Bandarra, N. M., & Lopes, P. A. (2025) · Cells · doi:10.3390/cells15010008 · Cited by 2 · see citing works

Sex-dependent effects of ultra-low-dose-THC preventive treatment on neuroinflammation and cognitive decline in 5xFAD mice

Nitzan, K., Bentulila, Z., Bregman-Yemini, N., Ayalon, N., David, D., Break, E. P., Sarne, Y., & Doron, R. (2026) · Biology of Sex Differences · doi:10.1186/s13293-025-00815-3 · Cited by 2 · see citing works

Ultrasound enhances glymphatic-associated solute transport via Piezo1-related mechanotransduction in 5xFAD mice

Zhang, L., He, K., Zhang, H., Wu, L., Gao, C., Liu, A., Qiu, S., Sun, Q., & Gao, Q. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261470064 · Cited by 2 · see citing works

The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer’s Disease

Migliorati, M., Manrique, C., Rahrah, M., Escoffier, G., Ahmadi, A. E., Girard, S. D., Khrestchatisky, M., Rivera, S., Baranger, K., & Roman, F. S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220281 · Cited by 2 · see citing works

Alzheimer model 5xfad mice and applications to dementia

Ayabe, T., & Ano, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00052-9 · Cited by 2 · see citing works

Early sensory deficits in Alzheimer’s disease: A review of potential integrating diagnostic methods

Yang, Y. (2024) · Journal of Clinical and Translational Science · doi:10.1017/cts.2024.525 · Cited by 2 · see citing works

Current progress in pathway-targeted therapeutics for Alzheimer’s disease: mechanistic insights and windows of opportunity

Ahmad, H. A., Zafar, M., Khan, T., & Khan, M. I. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05505-1 · Cited by 1 · see citing works

Dietary synergy of chub mackerel and quinoa in reducing cognitive decline and retinal degeneration in the 5XFAD Alzheimer's mouse model

Gomes‐Bispo, A., de Mello-Sampayo, C., Camacho, P., Rego, B., Carvalho, S., Lopes, P. A., Gomes, R., Oliveira, S., Lourenço, M., Pinto, R. M. A., et al. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45219 · Cited by 1 · see citing works

Rapid Microbial Profiling through Multimodal Biosensors for Transversal Analysis

Lee, J.-H., Chin, S. M., Chan, D. C., Liao, J. C., Yang, S. S., Zhang, N., & Wong, P. K. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02449 · Cited by 1 · see citing works

HSPA13 gene and microRNA-155: relationship between Down syndrome and Alzheimer’s disease

Gomes, F. D. C., Bertelli, B. P., de Souza, C. P., Santos, D. R. D. O., Neto, J. S. D. M., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0239 · Cited by 1 · see citing works

Animal Models for Brain Research

Dam, D. V., & Deyn, P. P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_1 · Cited by 1 · see citing works

Procognitive and neurotrophic benefits of α5-GABA-A receptor positive allosteric modulation in a β-amyloid deposition model of Alzheimer’s disease pathologyPreprint

Bernardo, A. M., Marcotte, M. D., Wong, K. D., Sharmin, D., Pandey, K. P., Cook, J. M., Sibille, E. L., & Prévot, T. D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.30.510361 · Cited by 1 · see citing works

Electro-Calcium uncoupling precedes neurodegeneration in Alzheimer’s diseasePreprint

Kwon, H. C., Eiden, A. M., Li, J., MacKinnon, M., Garfinkel, J. B., Hooper, S., Liu, Y., Nelson, M. T., Koretsky, A. P., & Mughal, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701803 · Cited by 1 · see citing works

SLEEP ALTERATIONS IN MOUSE GENETIC MODELS OF HUMAN DISEASE

Sethi, M. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.522

Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies

Murshid, N. M., Sahardi, N. F. N. M., & Makpol, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010241

Additional file 1 of Repetitive transcranial magnetic stimulation increases the brain’s drainage efficiency in a mouse model of Alzheimer’s disease

Lin, Y., Jin, J., Lv, R., Luo, Y., Dai, W., Li, W., Tang, Y., Wang, Y., Ye, X., & Lin, W.-J. (2021) · Figshare · doi:10.6084/m9.figshare.14722040

Additional file 2 of Repetitive transcranial magnetic stimulation increases the brain’s drainage efficiency in a mouse model of Alzheimer’s disease

Lin, Y., Jin, J., Lv, R., Luo, Y., Dai, W., Li, W., Tang, Y., Wang, Y., Ye, X., & Lin, W.-J. (2021) · Figshare · doi:10.6084/m9.figshare.14722043

Mouse models of Alzheimer’s disease pathology

Kim, S., & Gray, N. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29090-9.00004-0

Métalloprotéases matricielles et maladie d'Alzheimer : étude du rôle de MT1-MMP dans le métabolisme de l'APP/Aß

Py, N. A. (2014) · theses.fr (ABES) · doi:10.70675/76e6e222zc088z470cza0c6za5a23187870c

Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer’s disease

Girard, S. D., Jacquet, M., Baranger, K., Migliorati, M., Escoffier, G., Bernard, A., Khrestchatisky, M., Féron, F., Rivera, S., Roman, F. S., et al. (2014) · Hippocampus · doi:10.1002/hipo.22267 · Cited by 119 · see citing works

4-Hydroxynonenal Immunoreactivity Is Increased in the Frontal Cortex of 5XFAD Transgenic Mice

Shin, S.-W., Kim, D.-H., Jeon, W. K., & Han, J. (2020) · Biomedicines · doi:10.3390/biomedicines8090326 · Cited by 17 · see citing works

P1‐043: Behavioral and magnetic resonance microscopic studies of a transgenic mouse model of Alzheimer's disease

Banks, B., Pych, J. C., Venkatasubramanian, P. N., & Wyrwicz, A. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.628

IC‐P1‐065: Behavioral and magnetic resonance microscopic studies of a transgenic mouse model of AD

Venkatasubramanian, P. N., Banks, B., Pych, J. C., & Wyrwicz, A. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.2507

O2‐04‐03: MEMORY DEFICITS OF 5XFAD MICE IN THE OLFACTORY H‐MAZE TEST CORRELATE WITH PLAQUES DEVELOPMENT AND ARE PREVENTED BY 5‐HT4R AGONIST TREATMENTS

Giannoni, P., Baranger, K., Girot, S., Girard, S. D., Gaven, F., Jacquet, M., Migliorati, M., Rivera, S., Claeysen, S., & Roman, F. S. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.175